Contraceptive Technology Update
RSSArticles
-
Injectable Implant Focus of HIV Treatment/ Prevention Research
Researchers with the University of North Carolina at Chapel Hill and the Centers for Disease Control and Prevention are examining a new drug delivery system that uses dolutegravir, an established HIV drug, in a potential longacting treatment and prevention system. The system has been tested in animal models.
-
Research Strides May Offer Keys to Battling Gonorrhea
Researchers are investigating a rapid test that not only checks for gonorrhea infection, but also signals if a particular strain is antibiotic-resistant. On another front, scientists report that one dose of a developmental oral antibiotic proves effective in treating uncomplicated genital infections caused by gonorrhea.
-
Researchers Release Initial Results on Developmental Vaginal Ring
In an effort to provide both HIV/AIDS and unintended pregnancy protection, researchers have developed a vaginal ring containing the antiretroviral drug dapivirine and the contraceptive hormone levonorgestrel. Scientists have just released results of an initial clinical trial, noting no safety issues.
-
FDA Move Widens Approved Use of Human Papillomavirus Vaccine
The Food and Drug Administration has approved the use of the nine-valent human papillomavirus (HPV) vaccine in women and men ages 27-45. The Advisory Committee on Immunization Practices (ACIP) is scheduled to review further information at its February 2019 meeting, with a potential vote at that time. Insurance reimbursement often is based on ACIP guidance.
-
With Reclassification and New Name, Doors May Open for Internal Condom
The Food and Drug Administration has reclassified the female condom from a Class III device to a Class II device, putting it in the same category as the male condom.
-
Eliminate Barriers to Expedited Partner Therapy
Since 2006, the Centers of Disease Control and Prevention has recommended the use of expedited partner therapy (EPT) for treatment of sexually transmitted infections such as gonorrhea and chlamydia, but the infection rate continues to climb.
-
What Can Clinicians Do to Combat Increase in Congenital Syphilis Rates?
Cases of congenital syphilis have more than doubled since 2013, according to the Centers for Disease Control and Prevention. All pregnant women should visit a healthcare provider as soon as possible to be tested for syphilis, but one test may not be enough to catch all cases.
-
Abortion Access in the United States: Adolescents and Women of Color Face Increased Barriers
When accessing reproductive health services, particularly abortion, young people face additional barriers, such as cost, stigma, confidentiality, and privacy concerns.
-
Research Focuses on Untreated Genital Warts and HIV Risk
New research indicates that genital warts may lead to a higher risk of acquiring HIV from a partner who is infected because anogenital warts may be especially susceptible to the infection.
-
Consider Options for Women With Genitourinary Syndrome of Menopause
Sexual function often decreases for women because of the genitourinary syndrome of menopause (GSM). This condition includes the physical changes of the vulva, vagina, and lower urinary tract that result from estrogen deficiency.